More

‘CRUSH USH’ The Central Committee on Research Involving Human Subjects (CCMO) has given the Usher Syndrome expertise centre in Radboud UMC permission to actually start the CRUSH study. The CCMO assesses whether medical scientific research complies with the legal stipulations. With this the CCMO guarantees the protection of participants of

The RUSH2a and the CRUSH studies By now, both the RUSH2a and the CRUSH studies have been started in the Usher Syndrome Expertise Centre in Radboud UMC in Nijmegen, the Netherlands. What are the differences and the similarities? We will explain below. CRUSH has been aligned to RUSH2aAlso thanks to

More

Foundation Fighting Blindness will provide up to $7.5 million in funding to develop ProQR’s candidate QR-421a for Usher syndrome type 2A Foundation Fighting Blindness and ProQR Therapeutics N.V. , announced that they have entered into a partnership to develop QR-421a for Usher syndrome 2A caused by an exon 13 mutation

Source: Usher syndrome Coalition USH Talk By Hannie Kremer Date: 30 – 5 – 2017 In this USH Talk, Dr. Hannie Kremer explains genetic testing of the USH2A gene, as conducted at the Radboud University Medical Center in Nijmegen, Netherlands. The type of DNA defects found in this gene is